Nextage Therapeutics (Israel) Today
| NXTG Stock | ILA 72.50 4.90 7.25% |
Performance10 of 100
| Odds Of DistressLess than 23
|
Nextage Therapeutics is trading at 72.50 as of the 19th of April 2024, a 7.25 percent increase since the beginning of the trading day. The stock's open price was 67.6. Nextage Therapeutics has about a 23 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat ok performance during the last 90 days. Equity ratings for Nextage Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Nextage Therapeutics Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. The company was formerly known as Micromedic Technologies Ltd and changed its name to Nextage Therapeutics Ltd in August 2020. NEXTAGE THERAPEUTI operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange.. The company has 26.14 M outstanding shares. More on Nextage Therapeutics
Moving together with Nextage Stock
| 0.97 | MCTC | Nextage Therapeutics | PairCorr |
Moving against Nextage Stock
| 0.76 | BEZQ | Bezeq Israeli Teleco | PairCorr |
| 0.7 | KMDA | Kamada | PairCorr |
| 0.53 | NSTR | Norstar | PairCorr |
| 0.5 | REKA | Rekah Pharmaceutical | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Nextage Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Nextage Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nextage Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Nextage Therapeutics (NXTG) is traded on Tel Aviv Stock Exchange in Israel and employs 65 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nextage Therapeutics's market, we take the total number of its shares issued and multiply it by Nextage Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nextage Therapeutics operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 26.14 M outstanding shares.
Nextage Therapeutics has accumulated about 358 K in cash with (3.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Check Nextage Therapeutics Probability Of Bankruptcy
Ownership AllocationNextage Therapeutics holds a total of 26.14 Million outstanding shares. Nextage Therapeutics secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.36 % of Nextage Therapeutics outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Nextage Ownership Details
Nextage Stock Price Odds Analysis
What are Nextage Therapeutics' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Nextage Therapeutics jumping above the current price in 90 days from now is near 1%. The Nextage Therapeutics probability density function shows the probability of Nextage Therapeutics stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Nextage Therapeutics has a beta of -1.1003. This indicates Moreover, nextage Therapeutics has an alpha of 1.822, implying that it can generate a 1.82 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Nextage Therapeutics to move above the current price in 90 days from now is near 1 (This Nextage Therapeutics probability density function shows the probability of Nextage Stock to fall within a particular range of prices over 90 days) .
Nextage Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Nextage Therapeutics market risk premium is the additional return an investor will receive from holding Nextage Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Nextage Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Nextage Therapeutics' alpha and beta are two of the key measurements used to evaluate Nextage Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.41 | |||
| Semi Deviation | 3.97 | |||
| Standard Deviation | 11.64 | |||
| Variance | 135.39 |
Nextage Stock Against Markets
Picking the right benchmark for Nextage Therapeutics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Nextage Therapeutics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Nextage Therapeutics is critical whether you are bullish or bearish towards Nextage Therapeutics at a given time. Please also check how Nextage Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nextage Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
How to buy Nextage Stock?
Before investing in Nextage Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Nextage Therapeutics. To buy Nextage Therapeutics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Nextage Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Nextage Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Nextage Therapeutics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Nextage Therapeutics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Nextage Therapeutics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Nextage Therapeutics?
The danger of trading Nextage Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Nextage Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Nextage Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Nextage Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nextage Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Nextage Stock analysis
When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |